Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia

NCT03743961 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2020-07-07

No results posted yet for this study

Summary

The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia

Conditions

  • Systemic Treatment
  • Metastatic Neoplasia
  • Elderly Patients

Interventions

OTHER

geriatric intervention

Geriatric intervention

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    lead OTHER

Principal Investigators

  • Blandine De Lavigerie, MD · Institut de Cancérologie Lucien Neuwirth

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-21
Primary Completion
2020-07-02
Completion
2020-07-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743961 on ClinicalTrials.gov